by James Rudge, PhD, Technical Director, Neoteryx | 5 min read
An article published by Iris Xie, Yang Xu and Kevin Bateman et al in the April 2018 issue of the Journal of Pharmaceutical and Biomedical Analysis, reported on the importance …
Read Storyby Neoteryx | 4 min read
Blood sampling is an invaluable part of clinical research, but blood collection methods and blood storage chains are resource-intensive and sometimes wasteful. Most traditional blood collection methods require in-patient visits …
Read Storyby Neoteryx | 4 min read
As the COVID-19 crisis continues to wreak havoc on public health, international relations and the world economy, all eyes are on our research scientists in the hope they can develop …
Read Storyby Neoteryx | 1 min read
When Fasha Mahjoor launched Neoteryx, he planned to change the way dried capillary blood is collected, to become the most significant blood microsampling innovator in the modern marketplace. In that, …
Read Storyby Neoteryx | 2 min read
Therapeutic drug monitoring (TDM) immunosuppressants are a critical component of post-tissue and organ transplantation therapy. This is because ISP drugs have high intra- and inter-subject variability and a narrow therapeutic …
Read Storyby Neoteryx | 2 min read
When administering immunosuppressants, clinicians need to individualize a patient’s drug therapy. The goal is to attain an optimal balance between therapeutic efficacy and the probability of adverse effects. Patients present …
Read Story